1. AB0003 A mif promoter polymorphism is associated with the susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis patients. (15th June 2017) Authors: Lόpez-Isac, E; Bossini-Castillo, L; Campillo-Davό, D; Carmona, FD; Simeόn, CP; Carreira, P; Callejas-Rubio, JL; Castellví, I; Fernández-Nebro, A; Rodríguez-Rodríguez, L; Rivas, M Rubio; García, FJ Hernández; Madroñero, AB; Group, S Scleroderma; Beretta, L; Santaniello, A; Lunardi, C; Airό, P; Hof... Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0010 Lilrb3 expression on t cells correlates with disease activity in ra. (15th June 2017) Authors: Holz, A; Witte, T; Schmidt, RE Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Issue 3 (3rd December 2010) Authors: Diaz-Gallo, LM; Gourh, P; Broen, J; Simeon, C; Fonollosa, V; Ortego-Centeno, N; Agarwal, S; Vonk, MC; Coenen, M; Riemekasten, G; Hunzelmann, N; Hesselstrand, R; Tan, FK; Reveille, JD; Assassi, S; García-Hernandez, FJ; Carreira, P; Camps, MT; Fernandez-Nebro, A; de la Peña, P Garcia Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 3(2011) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Issue 12 (13th July 2005) Authors: Zandman-Goddard, G; Blank, M; Langevitz, P; Slutsky, L; Pras, M; Levy, Y; Shovman, O; Witte, T; Doria, A; Rovensky, J; Shoenfeld, Y Journal: Annals of the rheumatic diseases Issue: Volume 64:Issue 12(2005) Page Start: 1698 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Issue 6 (5th January 2012) Authors: Baerlecken, N T; Linnemann, A; Gross, W L; Moosig, F; Vazquez-Rodriguez, T R; Gonzalez-Gay, M A; Martin, J; Kötter, I; Henes, J C; Melchers, I; Vaith, P; Schmidt, R E; Witte, T Journal: Annals of the rheumatic diseases Issue: Volume 71:Issue 6(2012) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Autoantibodies against CD74 in spondyloarthritis. Issue 6 (17th May 2013) Authors: Baerlecken, N T; Nothdorft, S; Stummvoll, G H; Sieper, J; Rudwaleit, M; Reuter, S; Matthias, T; Schmidt, R E; Witte, T Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 6(2014) Page Start: 1211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Autoantibodies binding to ubiquitin‐fold modifier‐conjugating enzyme 1 (Ufc1) and pleckstrin homology domain containing, family G (with RhoGef domain) member 2 (Plekhg2) are associated with mycobacterial infections. Issue 2 (12th September 2014) Authors: Tellermann, A; Witte, T; Lansche, C; Stoll, M; Schmidt, RE; Baerlecken, NT Journal: HIV medicine Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Breast cancer in systemic lupus. (March 2017) Authors: Bernatsky, S; Ramsey-Goldman, R; Petri, M; Urowitz, M B; Gladman, D D; Fortin, P F; Ginzler, E; Romero-Diaz, J; Peschken, C; Jacobsen, S; Hanly, J G; Gordon, C; Nived, O; Yelin, E H; Isenberg, D; Rahman, A; Bae, S-C; Joseph, L; Witte, T; Ruiz-Irastorza, G Journal: Lupus Issue: Volume 26:Number 3(2017) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus. Issue 1 (December 2015) Authors: Günther, C; Kind, B; Reijns, MAM; Berndt, N; Martinez-Bueno, M; Wolf, C; Tüngler, V; Chara, O; Lee, YA; Hübner, N; Lee, YA; Bicknell, L; Blum, S; Krug, C; Schmidt, F; Krug, C; Kretschmer, S; Koss, S; Astell, KR; Ramantani, G Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus. Issue 1 (December 2015) Authors: Günther, C; Kind, B; Reijns, MAM; Berndt, N; Martinez-Bueno, M; Wolf, C; Tüngler, V; Chara, O; Lee, YA; Hübner, N; Lee, YA; Bicknell, L; Blum, S; Krug, C; Schmidt, F; Krug, C; Kretschmer, S; Koss, S; Astell, KR; Ramantani, G Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗